ocular disease

R&D

pharmaphorum podcast Episode 253, Lance Baldo, Beacon Therapeutics

Looking to gene therapy for ocular diseases, with Lance Bald...

Lance Baldo, CEO of Beacon Therapeutics, discusses the transformative power of gene therapy to deliver meaningful outcomes for severe ocular diseases.

R&D

Global communication network around planet Earth in space, worldwide exchange of information by internet and connected satellites for finance, cryptocurrency or IoT technology

Breaking into the global pharmaceutical market

In 2022, pharma is truly a global industry, and innovation can come from anywhere.

Partner Content

Partner Content

Registration opens for SMi’s 4th Annual Ophthalmic Drugs Con...

Registration opens for Ophthalmic Drugs Conference

Looking to gene therapy for ocular diseases, with Lance Bald...

Breaking into the global pharmaceutical market

Registration opens for SMi’s 4th Annual Ophthalmic Drugs Con...

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks